Review





Similar Products

94
Miltenyi Biotec psc derived cardiomyocyte isolation kit
Differentiation protocol and subsequent purification, with Pb exposure on the first 8 days of differentiation, purification between days 10-20, and optical mapping performed for purified <t>cardiomyocytes</t> 7-10 days after purification.
Psc Derived Cardiomyocyte Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/PSC-Derived+Cardiomyocyte+Isolation+Kit%2C+human/bio_rxiv__64898__2026__10__01__755665-39-21-26
Average 94 stars, based on 1 article reviews
psc derived cardiomyocyte isolation kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Celprogen Inc human cardiomyocyte cells
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
Human Cardiomyocyte Cells, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Cell+Culture/pmc13409955-42-0-6
Average 93 stars, based on 1 article reviews
human cardiomyocyte cells - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
PromoCell hcm c 12810
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
Hcm C 12810, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiac+Myocytes/pm42816593-312-0-8
Average 95 stars, based on 1 article reviews
hcm c 12810 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Axol Bioscience human induced pluripotent stem cell derived ventricular cardiomyocytes
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
Human Induced Pluripotent Stem Cell Derived Ventricular Cardiomyocytes, supplied by Axol Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/Human+iPSC-Derived+Ventricular+Cardiomyocytes/10__3390_slash_life16101627-89-5-16
Average 94 stars, based on 1 article reviews
human induced pluripotent stem cell derived ventricular cardiomyocytes - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
ATCC human cardiomyocyte ac16 cell line
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
Human Cardiomyocyte Ac16 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/AC16/pm42600511-312-1-6
Average 97 stars, based on 1 article reviews
human cardiomyocyte ac16 cell line - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

95
PromoCell c 12810
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
C 12810, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiac+Myocytes/10__1038_slash_s41419___026___09229___4-85-22-21
Average 95 stars, based on 1 article reviews
c 12810 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

97
ATCC human ventricular cardiomyocyte line ac16
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
Human Ventricular Cardiomyocyte Line Ac16, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/AC16/pm41944987-64-1-9
Average 97 stars, based on 1 article reviews
human ventricular cardiomyocyte line ac16 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
Celprogen Inc human cardiomyocyte serum free media
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
Human Cardiomyocyte Serum Free Media, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Serum+Free+Media/pmc13409955-37-6-10
Average 94 stars, based on 1 article reviews
human cardiomyocyte serum free media - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Celprogen Inc human cardiomyocyte complete media with serum
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
Human Cardiomyocyte Complete Media With Serum, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Complete+Media+with+Serum/custom%40m36044-15s%4042505916
Average 93 stars, based on 1 article reviews
human cardiomyocyte complete media with serum - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Celprogen Inc e36044 15 t25
Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of <t>cardiomyocyte</t> cells.
E36044 15 T25, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Primary+Cell+Culture+Extracellular+Expansion+Matrix/pmc13409955-46-1-2
Average 90 stars, based on 1 article reviews
e36044 15 t25 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Differentiation protocol and subsequent purification, with Pb exposure on the first 8 days of differentiation, purification between days 10-20, and optical mapping performed for purified cardiomyocytes 7-10 days after purification.

Journal: bioRxiv

Article Title: Lead Exposure During Differentiation Perturbs Electrophysiological Function in iPSC-Derived Cardiomyocytes in a Cell Line-Dependent Manner

doi: 10.64898/2026.10.01.755665

Figure Lengend Snippet: Differentiation protocol and subsequent purification, with Pb exposure on the first 8 days of differentiation, purification between days 10-20, and optical mapping performed for purified cardiomyocytes 7-10 days after purification.

Article Snippet: Cardiomyocytes derived above (both control and Pb exposed) were purified once beating was visualized throughout each well (days 10-20), using the PSC-Derived Cardiomyocyte Isolation Kit (#130-110-188, Miltenyi Biotec, Bergisch Gladbach, Germany) as described. ( ) This kit employs a selective depletion strategy to enhance the cardiomyocyte purity to 98%.

Techniques: Purification

For ECC genes ATP2A2 , CACNA1C, RYR2 , and SLC8A1 and K channel subunits HERG1A and B, no significant changes were observed for purified cardiomyocytes for either female or male cells treated with 0.5 and 5 µM Pb during the first 8 days of differentiation (n = 3 per cell line per treatment; one-way ANOVA p-values for each comparison labeled on the graphs).

Journal: bioRxiv

Article Title: Lead Exposure During Differentiation Perturbs Electrophysiological Function in iPSC-Derived Cardiomyocytes in a Cell Line-Dependent Manner

doi: 10.64898/2026.10.01.755665

Figure Lengend Snippet: For ECC genes ATP2A2 , CACNA1C, RYR2 , and SLC8A1 and K channel subunits HERG1A and B, no significant changes were observed for purified cardiomyocytes for either female or male cells treated with 0.5 and 5 µM Pb during the first 8 days of differentiation (n = 3 per cell line per treatment; one-way ANOVA p-values for each comparison labeled on the graphs).

Article Snippet: Cardiomyocytes derived above (both control and Pb exposed) were purified once beating was visualized throughout each well (days 10-20), using the PSC-Derived Cardiomyocyte Isolation Kit (#130-110-188, Miltenyi Biotec, Bergisch Gladbach, Germany) as described. ( ) This kit employs a selective depletion strategy to enhance the cardiomyocyte purity to 98%.

Techniques: Purification, Comparison, Labeling, Gene Expression

Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of cardiomyocyte cells.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of cardiomyocyte cells.

Article Snippet: Human cardiomyocyte cells were obtained from Celprogen Inc. (Cat.

Techniques:

( A , B ) The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on cytosolic calcium levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM, on the 20th cycle) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 3). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM group.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: ( A , B ) The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on cytosolic calcium levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM, on the 20th cycle) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 3). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM group.

Article Snippet: Human cardiomyocyte cells were obtained from Celprogen Inc. (Cat.

Techniques: Control

The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on apoptosis levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.005 and d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on apoptosis levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.005 and d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM.

Article Snippet: Human cardiomyocyte cells were obtained from Celprogen Inc. (Cat.

Techniques: Control

The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on reactive oxygen and mitochondrial depolarisation levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, e p ˂ 0.001 and f p ˂ 0.05 vs. REM, and g p ˂ 0.001 vs. SEV + REM.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on reactive oxygen and mitochondrial depolarisation levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, e p ˂ 0.001 and f p ˂ 0.05 vs. REM, and g p ˂ 0.001 vs. SEV + REM.

Article Snippet: Human cardiomyocyte cells were obtained from Celprogen Inc. (Cat.

Techniques: Control

The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on caspase-3 and caspase-9 levels in the cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.001 vs. REM, and d p ˂ 0.001 vs. SEV + REM.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on caspase-3 and caspase-9 levels in the cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.001 vs. REM, and d p ˂ 0.001 vs. SEV + REM.

Article Snippet: Human cardiomyocyte cells were obtained from Celprogen Inc. (Cat.

Techniques: Control

Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of cardiomyocyte cells.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of cardiomyocyte cells.

Article Snippet: Human Cardiomyocyte Complete Media with Serum, Human Cardiomyocyte Serum-Free Media (Celprogen, Torrance, CA, USA), Trypsin–EDTA, dimethyl sulfoxide, and Dihydrorhodamine-123 (DHR 123) were procured from Sigma-Aldrich (St. Louis, MO, USA).

Techniques:

( A , B ) The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on cytosolic calcium levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM, on the 20th cycle) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 3). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM group.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: ( A , B ) The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on cytosolic calcium levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM, on the 20th cycle) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 3). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM group.

Article Snippet: Human Cardiomyocyte Complete Media with Serum, Human Cardiomyocyte Serum-Free Media (Celprogen, Torrance, CA, USA), Trypsin–EDTA, dimethyl sulfoxide, and Dihydrorhodamine-123 (DHR 123) were procured from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Control

The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on apoptosis levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.005 and d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on apoptosis levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.005 and d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM.

Article Snippet: Human Cardiomyocyte Complete Media with Serum, Human Cardiomyocyte Serum-Free Media (Celprogen, Torrance, CA, USA), Trypsin–EDTA, dimethyl sulfoxide, and Dihydrorhodamine-123 (DHR 123) were procured from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Control

The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on reactive oxygen and mitochondrial depolarisation levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, e p ˂ 0.001 and f p ˂ 0.05 vs. REM, and g p ˂ 0.001 vs. SEV + REM.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on reactive oxygen and mitochondrial depolarisation levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, e p ˂ 0.001 and f p ˂ 0.05 vs. REM, and g p ˂ 0.001 vs. SEV + REM.

Article Snippet: Human Cardiomyocyte Complete Media with Serum, Human Cardiomyocyte Serum-Free Media (Celprogen, Torrance, CA, USA), Trypsin–EDTA, dimethyl sulfoxide, and Dihydrorhodamine-123 (DHR 123) were procured from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Control

The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on caspase-3 and caspase-9 levels in the cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.001 vs. REM, and d p ˂ 0.001 vs. SEV + REM.

Journal: Journal of Cardiovascular Development and Disease

Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels

doi: 10.3390/jcdd13070339

Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on caspase-3 and caspase-9 levels in the cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.001 vs. REM, and d p ˂ 0.001 vs. SEV + REM.

Article Snippet: Human Cardiomyocyte Complete Media with Serum, Human Cardiomyocyte Serum-Free Media (Celprogen, Torrance, CA, USA), Trypsin–EDTA, dimethyl sulfoxide, and Dihydrorhodamine-123 (DHR 123) were procured from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Control